StockNews.com started coverage on shares of NeuroMetrix (NASDAQ:NURO – Get Rating) in a research report report published on Sunday. The brokerage issued a sell rating on the medical device company’s stock. NeuroMetrix Price Performance Shares of NASDAQ NURO opened at $1.04 on Friday. The business’s fifty day moving average price is $1.45 and its two-hundred […]
Stock analysts at StockNews.com began coverage on shares of NeuroMetrix (NASDAQ:NURO – Get Rating) in a research note issued on Sunday. The brokerage set a “sell” rating on the medical device company’s stock. NeuroMetrix Price Performance NURO stock opened at $1.06 on Friday. The business has a 50-day moving average price of $1.47 and a […]
StockNews.com started coverage on shares of NeuroMetrix (NASDAQ:NURO – Get Rating) in a research note issued to investors on Saturday morning. The brokerage issued a sell rating on the medical device company’s stock. NeuroMetrix Trading Up 1.5 % NASDAQ NURO opened at $1.39 on Friday. NeuroMetrix has a 1-year low of $1.33 and a 1-year […]
Item 2.02 Results of Operations and Financial Condition.
On May 3, 2023, NeuroMetrix, Inc. issued a press release announcing its
financial results for the quarter ended March 31, 2023. The full. | May 3, 2023
NeuroMetrix (NASDAQ:NURO – Get Rating) and Regenicin (OTCMKTS:RGIN – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership. Volatility and Risk NeuroMetrix has a beta of 2.29, meaning that […]